Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction

Oncology

Volumn 69, Issue 5, 2005, Pages 428-435

  Taniguchi, Kazuya ^a   Takano, Toru ^c   Miyauchi, Akira ^b   Koizumi, Kyoko ^c   Ito, Yasuhiro ^b   Takamura, Yuuki ^b   Ishitobi, Makoto ^c   Miyoshi, Yasuo ^c   Taguchi, Tetsuya ^c   Tamaki, Yasuhiro ^c   Kato, Kikuya ^c   Noguchi, Shinzaburo ^c  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b KUMA HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Differential diagnosis; Follicular tumor; Gene expression profile; Thyroid cancer

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 3; KERATIN; KERATIN 19; PROTEIN; RNA; THYROID PEROXIDASE; TREFOIL FACTOR 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ADAPTER TAGGED COMPETITIVE POLYMERASE CHAIN REACTION; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLE; SENSITIVITY AND SPECIFICITY; THYROID ADENOMA; THYROID CARCINOMA; UNINDEXED SEQUENCE; VALIDATION PROCESS;

ADENOMA; ALGORITHMS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERNET; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; TIME FACTORS;

EID: 29144473675     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089998     Document Type: Article

References (33)

1. Mazzaferri EL: Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-559.
2. Baloch ZW, Fleisher S, LiVolsi VA, et al: Diagnosis of 'follicular neoplasm': a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26:41-44.
3. Greaves TS, Olvera M, Florentine BD, et al: Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 2000;90:335-341.
4. Bartolazzi A, Gasbarri A, Papotti M, et al: Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001;357:1644-1650.
5. Inohara H, Honjo Y, Yoshii T, et al: Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 1999;85:2475-2484.
6. Cvejic D, Savin S, Paunovic I, et al: Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 1998;18:2637-2641.
7. Bernet VJ, Anderson J, Vaishnav Y, et al: Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2002;87:4792-4796.
8. Takano T, Miyauchi A, Matsuzuka F, et al: Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors. Cancer Lett 2003;199:69-73.
9. Kroll TG, Sarraf P, Pecciarini L, et al: PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma (corrected). Science 2000;289:1357-1360.
10. Marques AR, Espadinha C, Catarino AL, et al: Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2002;87:3947-3952.
11. Nikiforova MN, Biddinger PW, Caudill CM, et al: PAX8-PPARγ rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 2002;26:1016-1023.
12. Yamashita H, Noguchi S, Murakami N, et al: Immunohistological differentiation of benign thyroid follicular cell tumors from malignant ones: usefulness of anti-peroxidase and JT-95 antibodies. Acta Pathol Jpn 1993;43:670-673.
13. Fagin JA: Tumor suppressor genes in human thyroid neoplasms: p5 3 mutations are associated undifferentiated thyroid cancers. J Endocrinol Invest 1995;18:140-142.
14. Haugen BR, Nawaz S, Markham N, et al: Telomerase activity in benign and malignant thyroid tumors. Thyroid 1997;7:337-342.
15. Sack MJ, Astengo-Osuna C, Lin BT, et al: HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol 1997;10:668-674.
16. Takano T, Miyauchi A, Yoshida H, et al: High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer 2004;90:1600-1605.
17. Barden CB, Shister KW, Zhu B, et al: Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 2003;9:1792-1800.
18. Cerutti JM, Delcelo R, Amadei MJ, et al: A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 2004;113:1234-1242.
19. Kato K: Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression. Nucleic Acids Res 1997;25:4694-4696.
20. Iwao-Koizumi K, Matoba R, Ueno N, et al: Prediction of docetaxel response in human breast cancer by gene expression profiling. J Clin Oncol 2005;23:422-431.
21. Iwao K, Matoba R, Ueno N, et al: Molecular classification of primary breast tumors possessing distinct prognostic properties. Hum Mol Genet 2002;11:199-206.
22. Kurokawa Y, Matoba R, Nagano H, et al: Molecular prediction of response to 5-fluorouracil and interferon-α combination chemotherapy in advanced hepatocellular carcinoma. Clin Cancer Res 2004;10:6029-6038.
23. Kurokawa Y, Matoba R, Nakamori S, et al: PCR-array gene expression profiling of hepatocellular carcinoma. J Exp Clin Cancer Res 2004;23:135-141.
24. Kurokawa Y, Matoba R, Takemasa I, et al: Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J Hepatol 2003;39:1004-1012.
25. Muro S, Takemasa I, Oba S, et al: Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data. Genome Biol 2003;4:R21.
26. Huang Y, Prasad M, Lemon WJ, et al: Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 2001;98:15044-15049.
27. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
28. Reiner A, Yekutieli D, Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003;19:368-375.
29. Rhodes DR, Chinnaiyan AM: Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers. Ann NY Acad Sci 2004;1020:32-40.
30. Aratake Y, Kotani T, Tamura K, et al: Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol 1991;96:306-310.
31. Beesley MF, McLaren KM: Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 2002;41:236-243.
32. Pauws E, Veenboer GJ, Smit JW, et al: Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles. FASEB J 2004;18:560-561.
33. Holland MJ: Transcript abundance in yeast varies over six orders of magnitude. J Biol Chem 2002;277:14363-14366.